Wednesday, July 8, 2026

pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH

Aurinia Pharmaceuticals

Aurora Pharmaceutical is a pharma organization headquartered in northfield, USA. It trades on NYSE under ticker AUPH. Primary therapeutic focus areas include Lupus Nephritis, Generalized Myasthenia Gravis, Dry Eye Syndro

1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
Status
Public
HQ
1196 Hwy 3 South, Northfield, MN 55057, US
Founded
2007
Employees
81
Programs
14
Drugs
10
Patents
7
Clinical program

voclosporin

Phase 3 · small molecule · Psoriasis

voclosporin for Psoriasis is a Phase 3 program (small_molecule) at Aurinia Pharmaceuticals with 3 ClinicalTrials.gov record(s).

← All Aurinia Pharmaceuticals projects Phase 3 small molecule completed

Internal code ISA05-25

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Aurinia Pharmaceuticals
Phase
Phase 3
Modality
small_molecule
Indication
Psoriasis
Status
completed
Trials
3